Clinical trial
Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in…
NCT00214552 · Associated Scientists to Help Minimize Allergies, Other · Completed
Key facts
| NCT number | NCT00214552 |
|---|---|
| Title | Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. |
| Official title | A Double-blind Placebo Controlled Clinical Trial to Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. |
| Lead sponsor | Associated Scientists to Help Minimize Allergies, Other |
| Collaborators | Janssen Pharmaceuticals Industry Eisai Inc. |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma, Gastroesophageal Reflux Disease |
| Intervention type | Drug |
| Interventions | rabeprazole |
| Enrollment | 80 |
| Start date | Sep 1, 2002 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: